Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene for Ventricular Tachycardia in Heart Failure
jRCTs061180078Recruiting
- Start
- Mar 2011
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dantrolene in ventricular tachycardia (VT), heart failure (HF), catecholaminergic polymorphic ventricular tachycardia (CPVT) and 5 more. Primary endpoint: Safety of dantrolene. Started Mar 2011; status: recruiting.
02
Drugs
dantrolene
03
Conditions
ventricular tachycardia (VT)heart failure (HF)catecholaminergic polymorphic ventricular tachycardia (CPVT)arrhythmogenic right ventricular cardiomyopathy (ARVC)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on jRCTs061180078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180078.